Seaside Therapeutics is creating a new Autism drug treatment

Seaside Therapeutics Reports Positive Data from Phase 2 Study of STX209 in Autism Spectrum Disorders.  Study to Advance.

http://www.seasidetherapeutics.com/sites/default/files/news_media-release_2010-09-09.pdf

And reports advances in the treatment of Fragile X Syndrome.

http://www.seasidetherapeutics.com/sites/default/files/Seaside_ACS_release_5_18_2011.pdf

They have a pipeline summary of the drugs they are investigating for treatment of Autism and Fragile X.

http://www.seasidetherapeutics.com/pipeline-overview

May 1, 2011 · PTENLife · No Comments
Tags: , ,  · Posted in: Autism, PTEN Life, Treatment

Leave a Reply

*